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S U M M A R Y
In order to investigate the influence of substitution in the
pyrimidine nucleous on the activity of the three isomeric sulfanil-
amidopyrimidines (2, 5 and 6), a number of substituted sulfanil-
amidopyrimidines were synthesized and tested on chemotherapeutic
activity.
The sulfanilamide derivatives were obtained by interaction of
acetylsulfanilylchloride or p.nitrobenzenesulfonylchloride with amino-
pyrimidines, in the presence of anhydrous pyridine. The intermediate
acetylamino- or nitro-compounds were converted into the final
products by alkaline hydrolysis or by reduction with iron in
alcoholic solution.
In order to obtain the substituted aminopyrimidines, we prepared
the following three amino-chloro-methylpyrimidines'
N:CCI N-CH N-C. NH,
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2-amino-4-methyl- S-amino-2-chloro- 6-amino-2-chloro-
6-chloropyrimidine 4-methylpyrimidine 4-methylpyrimidine
We further made some amino-chloropyrimidines and one amino-
chloro-dimethylpyrimidine.
The chlorine atom in all these compounds is active. Catalytic
hydrogenation replaces it by a hydrogene atom. \il/hen reacting
with sodium alkanolates, sodium mercaptides or aniline, the chlorine
atom is replaced by an alkoxy, an alkylthio or an anilino group.
A number of the substituted aminopyrimidine derivatives were
hitherto unknown in chemical literature.
The synthesis of these compounds was worked out.
An investigation of the chemotherapeutic activity of the sulfanil-
amidopyrimidines was made in white mice that had been infected
with oneumococci.
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The mice were injected intraperitoneally with 0.5 ml of the
dilution 5.10-5 of a 17 hours old culture in 60/. ascites broth
of pneumococcus type I (named America I 1)). In this manner the
inoculum contained about 20000 organisms (2000 - 4000 M.L.D.).
Once a day 0.4 ml of a l0 o/o suspension of the drug in water (40 mg)
was administered by a stomach tube, the first time immediately
before the infection. The treatment was continued for five days,
unless the mouse died before.
The effect of the administering of the compound in infected
mice was traced by suspending a loopful of blood from the tail
twice daily in ascites agar, and counting the resulting pneumococcus
colonies. Besides the mouse which was infected and treated with
the investigated compound (test mouse), another was infected and
treated with sulfanilamidopyridine (dag6nan mouse); a third mouse
(control) was only infected with an equal dosis of the same culture
of pneumococci. By comparing the course of the septicemia in these
three mice, we deduced the activity of the compound. Each
sulfanilamide derivative was tested in two such series (test mouse,
dagdnan mouse and control mouse).
For the results see the table on p. 69.
The three isomeric sulfanilamido-4-methylpyrimidines have an
equal or larger activity as sulfanilamidopyridine; consequently the
position of the sulfanilamido group has no influence in this case.
The presence of a methyl group in position 4 of the pyrimidine
nucleus proved to increase the activity of the compound; this was
especially the case with the 6-sulfanilamidopyrimidines.
The introduction of a methyl group in position 5 decreases the
activity. The presence of several other groups (methoxy, methylthio,
phenylthio, anilino) has the same effect, and increases the toxicity
in some cases. The last property depends on the position of the
sulfanilamido group.
t ;  See: J. Mulder, Antonie van Leeuwenhoek 6, 221 (1940).
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